The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Microbiota and enteric nervous system crosstalk in diabetic gastroenteropathy: bridging mechanistic insights to microbiome-based therapies
Open accessAbstract
Diabetes mellitus has emerged as a global public health crisis, with over half of patients experiencing gastrointestinal (GI) symptoms that exacerbate glucose fluctuations and impair quality of life. While prior research on the pathophysiology of diabetic gastroenteropathy (DGE) focused primarily on autonomic neuropathy, particularly involving the vagus nerve, recent studies have shifted toward the impairment of the enteric nervous system (ENS). As the largest autonomous neural network governing GI motility independent of central control, structural and functional abnormalities of the ENS constitute the fundamental pathological basis for DGE. This review first delineates gut microbial alterations in diabetes and mechanisms by which dysbiosis compromises the integrity of the ENS. Second, we analyze how microbiota-derived metabolites (short-chain fatty acids, bile acids, tryptophan), gut hormones (glucagon-like peptide-1, ghrelin), and neurotransmitters (acetylcholine, vasoactive intestinal peptide, nitric oxide) multitarget the ENS—collectively establishing the “microbiota-ENS axis” as the central hub for GI sensorimotor control. Finally, we provide an overview of preclinical and clinical evidence for microbiome-targeted therapies (probiotics, prebiotics, fecal microbiota transplantation) in alleviating DGE symptoms and repairing ENS while outlining translational challenges and future research priorities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These microbiota-related changes may also help explain the frequent overlap between upper and lower gastrointestinal symptoms, including the coexistence of constipation and gastroparetic complaints [43, 48].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Alterations in gut microbial composition may contribute to low-grade inflammation, barrier disfunction, and altered gut-brain signaling, influencing both gastric motility and symptom perception [46–48].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [48]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., Mbanya, J. C., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109119 · Cited by 10,123 · cited 1×
“Diabetes has become a global public health crisis, with epidemiological data revealing a prevalence of 10.5% among individuals aged 20 – 70 years, projected to climb to 12.2% by 2045 (Sun et al., 2021).”
InfluentialRinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462 · cited 1×
“Although the gut microbiota is initially established at birth, it evolves dynamically throughout life, modulated by host age, dietary patterns, and physical activity (Rinninella et al., 2019).”
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Formation of propionate and butyrate by the human colonic microbiota
Louis, P., & Flint, H. J. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13589 · Cited by 3,028
Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
Effects of probiotics, prebiotics, and synbiotics on human health
Markowiak, P., & Śliżewska, K. (2017) · Nutrients · doi:10.3390/nu9091021 · Cited by 2,401 · cited 1×
“Probiotics, prebiotics, and synbiotics have been shown in extensive clinical studies (Markowiak and S ́ liz ̇ ewska, 2017; Quigley, 2019; Mokkala et al., 2021; Wang et al., 2022a) to effectively treat gastrointestinal disorders, like functional dyspepsia, IBS, and chronic constipation, as well as…”
The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?
Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., & Balamurugan, R. (2020) · Nutrients · doi:10.3390/nu12051474 · Cited by 2,335 · cited 1×
“Magne et al. (2020). attribute these discrepancies to methodological heterogeneity, including variations in sample size, participant characteristics, and sequencing approaches (16S rRNA vs. metagenomics).”
Pattern recognition receptors in health and diseases
Li, D., & Wu, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00687-0 · Cited by 1,787 · cited 1×
“Additionally, TLRs recognize pathogen-associated molecular patterns and interfere with ENS signal transmission by detecting pathogen-associated molecular patterns (PAMPs) such as LPS and lipoproteins (Li and Wu, 2021).”
Role of gut microbiota in type 2 diabetes pathophysiology
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,708
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
Sanna, S., van Zuydam, N. R., Mahajan, A., Kurilshikov, A., Vich Vila, A., Võsa, U., Mujagic, Z., Masclee, A. A. M., Jonkers, D. M. A. E., Oosting, M., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0350-x · Cited by 1,539
Research works printed but not linked: 1
- Gershon, 1998, The Second Brain : The Scientific Basis of Gut Instinct and a Groundbreaking New Understanding of Nervous Disorders of the Stomach and Intestines
Cited by
Beyond Digestion: The Gut Microbiota as an Immune–Metabolic Interface in Disease Modulation
Mohammad, I., Ansari, M. R., Khan, M. S., Bari, M. N., Kamal, M. A., & Poyil, M. M. (2025) · Gastrointestinal Disorders · doi:10.3390/gidisord7040077 · Cited by 31
“These compounds can directly or indirectly affect neurotransmission, mood, and cognitive processes [69].”
Role of traditional Chinese medicine in combating metabolic disorders: A systematic review
Pathak, A., Agrawal, M., Sethi, P., Sahu, K. K., Sharma, M., Chaudhary, H., Kumar, D., Singh, T. G., & Kumar, M. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100703 · Cited by 4
Protective Effects of PACAP in Diabetic Complications: Retinopathy, Nephropathy and Neuropathy
Reglődi, D., Tamás, A., Bosnyák, I., Atlasz, T., Szabo, E., Li, L., Horváth, G., Opper, B., Kiss, P., Lucas, L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199650 · Cited by 3
“Diabetic gastroenteropathy is another common complication [214,215], and a study in diabetic pigs showed that PACAP-containing enteric neurons reacted sensitively to altered conditions, as immunoreactivity strongly increased in the small intestine, descending colon and stomach [216].”
Shukla, A., Yadav, M., Malik, M. Z., Aditya, A. K., Kumar, A., Tandon, R., Shalimar, & Ray, A. K. (2026) · 3 Biotech · doi:10.1007/s13205-025-04675-x · Cited by 2
“We observed that the oxidative phosphorylation (OXPHOS) pathway was highly enriched in the rural group, while”
Khan, Z., Khan, T., Khan, F., & Bashir, B. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014864 · Cited by 2
Metadata
- Authors
- Tao, W., Yu, Y., Tan, D., Huang, X., Huang, J., Lin, C., & Yu, R.
- Affiliations
- Hunan University of Traditional Chinese Medicine (CN)
- Guangzhou University of Chinese Medicine (CN)
- Corresponding author
- Yu, Rong
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2025-08-11
- Volume
- 15
- Pages
- 1603442-1603442
- ISSN
- 2235-2988 (ISSN-L)
- PMC
- PMC12375670
- OpenAlex
- W4413227848
- Cited by
- 9
- References
- 226
- Citations by year
- 2026: 6 · 2025: 3
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cellular and Infection Microbiology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- National Natural Science Foundation of China ([82330078])
- Natural Science Foundation of Hunan Province
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- enteric nervous system, gut microbiota, dysbiosis, short-chain fatty acids, bile acids, tryptophan metabolites, gastrointestinal hormones, glucagon-like peptide-1, ghrelin, neurotransmitters, acetylcholine, vasoactive intestinal peptide, nitric oxide, autonomic neuropathy, vagus nerve, gastrointestinal motility, probiotics, prebiotics, fecal microbiota transplantation, microbiota-based therapy
- MeSH terms
- Gastrointestinal Microbiome, Animals, Gastrointestinal Diseases, Humans, Enteric Nervous System, Diabetes Complications, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microbiota and enteric nervous system crosstalk in diabetic gastroenteropathy: bridging mechanistic insights to microbiome-based therapies. https://app.cochat.ai/papers/10.3389/fcimb.2025.1603442
- The paper
- Tao, W., Yu, Y., Tan, D., Huang, X., Huang, J., Lin, C., & Yu, R. (2025). Microbiota and enteric nervous system crosstalk in diabetic gastroenteropathy: bridging mechanistic insights to microbiome-based therapies. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1603442
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.